Is the treatment beneficial, experimental, or futile?
Schneiderman
L J
LJ
Department of Family and Preventive Medicine, School of Medicine, University of California, San Diego, USA.
Jecker
N S
NS
D000230:Adenocarcinoma / Q000191:economics / Q000628:therapy; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000191:economics; D001943:Breast Neoplasms / Q000191:economics / Q000628:therapy; D000529:Complementary Therapies; D003363:Cost Control / Q000331:legislation & jurisprudence; D030881:Disclosure; D005260:Female; D006805:Human Experimentation; D006801:Humans; D033222:Judicial Role; D018447:Medical Futility; D028701:Patient Rights; D018570:Risk Assessment; D013675:Technology, High-Cost / Q000331:legislation & jurisprudence; D036302:Therapeutic Human Experimentation; D035703:Therapies, Investigational; D016896:Treatment Outcome; D035501:Uncertainty; D014481:United States